This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
This research service covers key technological trends and developments across global analgesic products and technologies that are likely to have a high impact in the near future. Based on the observation of the global analgesic industry, advances and technological trends across existing and emerging technologies have been detailed. While providing ...
$4,950.00 -
07 Jul 2016 | Global
Regenerative Medicine - The Future of Therapy (TechVision)
After many years of basic research, regenerative medicine represents a remarkable foremost innovation in medical care. Comprising principles of stem cell technology and tissue engineering, also combining advanced biomaterials with small molecules and biologics, to replace or regenerate human tissues and organs and restore their functions, regenerat...
$4,950.00 -
29 Apr 2016 | Global
2016 Top Technologies in Medical Devices and Imaging (TechVision)
High-impact Technologies Poised to Propel the Healthcare Industry
TechVision's Medical Devices and Imaging technology cluster's latest research service profiles ten technologies that are expected to have a huge impact on the healthcare industry in the next two years. This report provides an overview of the ten technologies, and provides key pointers that are needed for strategic decision-making. Each of these tec...
$4,950.00 -
29 Apr 2016 | Global
Health & Wellness Top 10 Technologies--2016 (TechVision)
Top technology trends that are likely to have an impact in 2016
This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in biosimilars, cancer screening, molecular scissors, next generation stem cells, three-dimensional (3D) scaffolds, therapeutic antibodies, cancer immunotherapy, high throug...
$4,950.00 -
30 Mar 2016 | Global
Innovations in Global Proteomics Technologies Market
Advanced Mass Spectrometry (MS) Technologies, Bioinformatics Platforms and 3D Imaging Techniques to be Invigorated by Collaborative Endeavors
This research service covers key technological trends and developments in proteomic technologies that are likely to have a high impact in the near future. Based on the survey and observation of the global proteomics industry, advances and technological trends across existing and emerging proteomic technologies have been detailed. While providing br...
$4,950.00 -
30 Mar 2016 | Global
Next Generation Diabetes Therapy and Drug Delivery Technologies
Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory
Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...
$4,950.00 -
30 Mar 2016 | Global
Diagnostic Breakthroughs for Neurodegenerative Diseases
R&D on Overdrive to Address Intensifying Disease Burden, Neuroimaging Technologies to Remain Gold-standard for Neurodiagnostic Applications
This research service covers key technological trends and developments in diagnostics for neurodegenerative diseases, which are likely to have a high impact in the near future. The technologies present across the global neurodiagnostic industry have been covered under neurobiomarkers, neuroimaging and neuroinformatics segments. While providing brie...
$4,950.00
